Role of the syncytium in placenta-mediated complications of preeclampsia

Redman, 2005, Latest advances in understanding preeclampsia, Science, 308, 1592, 10.1126/science.1111726

Kaufmann, 2003, Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia, Biol Reprod, 69, 1, 10.1095/biolreprod.102.014977

Stepan, 2006, New insights into the biology of preeclampsia, Biol Reprod, 74, 772, 10.1095/biolreprod.105.045997

Benirschke, 1998, Remarkable placenta, Clin Anat, 11, 194, 10.1002/(SICI)1098-2353(1998)11:3<194::AID-CA8>3.0.CO;2-T

Benyo, 2001, Expression of inflammatory cytokines in placentas from women with preeclampsia, J Clin Endocrinol Metab, 86, 2505, 10.1210/jc.86.6.2505

Conrad, 1998, Circulating levels of immunoreactive cytokines in women with preeclampsia, Am J Reprod Immunol, 40, 102, 10.1111/j.1600-0897.1998.tb00398.x

Walsh, 2000, Placental isoprostane is significantly increased in preeclampsia, FASEB J, 14, 1289, 10.1096/fj.14.10.1289

Myatt, 2004, Oxidative stress in the placenta, Histochem Cell Biol, 122, 369, 10.1007/s00418-004-0677-x

Sikkema, 2001, Placental superoxide is increased in pre-eclampsia, Placenta, 22, 304, 10.1053/plac.2001.0629

Maynard, 2003, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, J Clin Invest, 111, 649, 10.1172/JCI17189

Venkatesha, 2006, Soluble endoglin contributes to the pathogenesis of preeclampsia, Nat Med, 12, 642, 10.1038/nm1429

Goswami, 2006, Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction, Placenta, 27, 56, 10.1016/j.placenta.2004.11.007

Knight, 1998, Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies, Br J Obstet Gynaecol, 105, 632, 10.1111/j.1471-0528.1998.tb10178.x

Poston, 2004, Trophoblast oxidative stress, antioxidants and pregnancy outcome--a review, Placenta, 25 Suppl A, S72, 10.1016/j.placenta.2004.01.003

Many, 2000, Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia, Am J Pathol, 156, 321, 10.1016/S0002-9440(10)64733-5

Myatt, 1996, Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action, Hypertension, 28, 488, 10.1161/01.HYP.28.3.488

Ishihara, 2002, Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation, Am J Obstet Gynecol, 186, 158, 10.1067/mob.2002.119176

Levy, 2002, Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression, Am J Obstet Gynecol, 186, 1056, 10.1067/mob.2002.122250

Hung, 2002, Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia, Circ Res, 90, 1274, 10.1161/01.RES.0000024411.22110.AA

Abrahams, 2004, First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis, Mol Hum Reprod, 10, 55, 10.1093/molehr/gah006

Runic, 1998, Apoptosis and Fas expression in human fetal membranes, J Clin Endocrinol Metab, 83, 660, 10.1210/jc.83.2.660

Runic, 1996, Expression of Fas ligand by human cytotrophoblasts: implications in placentation and fetal survival, J Clin Endocrinol Metab, 81, 3119, 10.1210/jc.81.8.3119

Neale, 2005, The role of Fas mediated apoptosis in preeclampsia, J Perinat Med, 33, 471, 10.1515/JPM.2005.085

Allaire, 2000, Placental apoptosis in preeclampsia, Obstet Gynecol, 96, 271, 10.1016/S0029-7844(00)00895-4

Neale, 2003, Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis, J Matern Fetal Neonatal Med, 13, 39, 10.1080/jmf.13.1.39.44

Guller, 2008, The placental syncytium and the pathophysiology of preeclampsia and intrauterine growth restriction: a novel assay to assess syncytial protein expression, Ann N Y Acad Sci, 1127, 129, 10.1196/annals.1434.015

Aly, 2004, Neutrophils are stimulated by syncytiotrophoblast microvillous membranes to generate superoxide radicals in women with preeclampsia, Am J Obstet Gynecol, 190, 252, 10.1016/j.ajog.2003.07.003

Gupta, 2005, A comparative study of the effect of three different syncytiotrophoblast micro-particles preparations on endothelial cells, Placenta, 26, 59, 10.1016/j.placenta.2004.04.004

Lok, 2008, Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia, Hypertens Pregnancy, 27, 344, 10.1080/10641950801955733

Cockell, 1997, Human placental syncytiotrophoblast microvillous membranes impair maternal vascular endothelial function, Br J Obstet Gynaecol, 104, 235, 10.1111/j.1471-0528.1997.tb11052.x

Johansen, 1999, Trophoblast deportation in human pregnancy--its relevance for pre-eclampsia, Placenta, 20, 531, 10.1053/plac.1999.0422

Redman, 2008, Circulating microparticles in normal pregnancy and pre-eclampsia, Placenta, 29 Suppl A, S73, 10.1016/j.placenta.2007.11.016

Orozco, 2008, Membrane protected apoptotic trophoblast microparticles contain nucleic acids: relevance to preeclampsia, Am J Pathol, 173, 1595, 10.2353/ajpath.2008.080414

Humphrey, 2005, Fibrin enhances differentiation, but not apoptosis, and limits hypoxic injury of cultured term human trophoblasts, Placenta, 26, 491, 10.1016/j.placenta.2004.08.011

Salafia, 1995, Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features, Am J Obstet Gynecol, 173, 1049, 10.1016/0002-9378(95)91325-4

Salafia, 1997, Placental pathology of absent and reversed end-diastolic flow in growth-restricted fetuses, Obstet Gynecol, 90, 830, 10.1016/S0029-7844(97)00473-0

Estelles, 1989, Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia, Blood, 74, 1332, 10.1182/blood.V74.4.1332.1332

Estelles, 1994, Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation, Blood, 84, 143, 10.1182/blood.V84.1.143.143

Estelles, 1996, Abnormal expression of plasminogen activator inhibitors in patients with gestational trophoblastic disease, Am J Pathol, 149, 1229

Di Santo, 2007, Dual in vitro perfusion of an isolated cotyledon as a model to study the implication of changes in the third trimester placenta on preeclampsia, Placenta, 28 Suppl A, S23, 10.1016/j.placenta.2007.01.009

Bahtiyar, 2007, Contrasting effects of chronic hypoxia and nitric oxide synthase inhibition on circulating angiogenic factors in a rat model of growth restriction, Am J Obstet Gynecol, 196, 10.1016/j.ajog.2006.07.048

Knapen, 1999, Glutathione and glutathione-related enzymes in decidua and placenta of controls and women with pre-eclampsia, Placenta, 20, 541, 10.1053/plac.1999.0408

Wang, 1996, Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas, J Soc Gynecol Investig, 3, 179, 10.1016/1071-5576(96)00015-9

Wang, 2001, Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia, Placenta, 22, 206, 10.1053/plac.2000.0608

Myatt, 1997, Differential localization of superoxide dismutase isoforms in placental villous tissue of normotensive, pre-eclamptic, and intrauterine growth-restricted pregnancies, J Histochem Cytochem, 45, 1433, 10.1177/002215549704501012

Guller, 2008, Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsia, Lab Invest, 88, 1057, 10.1038/labinvest.2008.74

Hellman, 2002, Ceruloplasmin metabolism and function, Annu Rev Nutr, 22, 439, 10.1146/annurev.nutr.22.012502.114457

Scheinberg, 1952, Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease), Science, 116, 484, 10.1126/science.116.3018.484

Lee, 1968, Iron metabolism in copper-deficient swine, J Clin Invest, 47, 2058, 10.1172/JCI105891

Roeser, 1970, The role of ceruloplasmin in iron metabolism, J Clin Invest, 49, 2408, 10.1172/JCI106460

Osaki, 1966, The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum, J Biol Chem, 241, 2746, 10.1016/S0021-9258(18)96527-0

Patel, 2002, Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury, J Neurosci, 22, 6578, 10.1523/JNEUROSCI.22-15-06578.2002

Engin-Ustun, 2005, Maternal serum ceruloplasmin in preeclampsia, Int J Gynaecol Obstet, 89, 51, 10.1016/j.ijgo.2005.01.024

Serdar, 2006, Serum iron and copper status and oxidative stress in severe and mild preeclampsia, Cell Biochem Funct, 24, 209, 10.1002/cbf.1235

Sarkar, 2003, Role of ceruloplasmin in macrophage iron efflux during hypoxia, J Biol Chem, 278, 44018, 10.1074/jbc.M304926200

Cester, 1994, Pregnancy induced hypertension: a role for peroxidation in microvillus plasma membranes, Mol Cell Biochem, 131, 151, 10.1007/BF00925951